ARC Clinical Research

ARC Clinical Research now open at ARC Wilson Parke

ARC is excited to announce the expansion of our clinical research program. ARC Clinical Research, opened Tuesday, November 1, at ARC Wilson Parke, offering more patients access to cutting-edge research beyond the rheumatology clinical trials ARC currently conducts.

Physician leader and ARC Rheumatologist Anurekha Chadha, MD, will serve as the Medical Director for ARC Clinical Research. Grace Bullock, RN, will manage the new service at ARC Wilson Parke. ARC physicians will provide oversight for research efforts, and ARC patients will be invited to participate in research projects.

“This is a great opportunity for Austin Regional Clinic to expand its role in the community and help all patients,” said Dr. Chadha. “It also gives people the opportunity to explore medical options that might otherwise not be available to them.”

For more information about ARC Clinical Research, and how to participate, click here or call 737-247-7240.

Tags: ARC Wilson Parke, ARC Clinical Research, Dr. Anurekha Chadha

More on this Topic

At ARC , Patients Can Also Participate in Critical Research

Austin Regional Clinic Wilson Parke  offers medical research to improve treatment for osteoarthritis, asthma and Type 2 diabetes – and is seeking neighboring residents interested in participating in new clinical trials. Local newspaper Community Impact detailed upcoming research “that can benefit the community as a whole.”

Q&A with Medical Director of ARC Clinical Research

ARC’s new Clinical Research division aims to bring patients more access to treatments that might otherwise not be available to them. Dr. Anurekha Chadha, Medical Director for the new division, explains how patients can enroll in the upcoming trials in an interview with Four Point News.

ARC Teams with Austin-based ENTvantage Diagnostics Dx for New Clinical Trial

ARC’s newest clinical trial tests a device that could help curb antibiotic overuse, "one of the most urgent threats to the public’s health,” according to the Centers for Disease Control (CDC).

ARC Clinical Research Featured in Community Impact

ARC Clinical Research, based at ARC Wilson Parke, is featured in an article in Community Impact’s Lake Travis/Westlake edition. The article explains ARC’s involvement in a global study for a new antiviral flu drug, Xofluza, that may be available as early as 2019.

ARC Clinical Research Studying Anti-Flu Drug in High-Risk Patients

ARC Clinical Research has been studying a new drug to fight the flu in high-risk patients, with the goal of being able to offer another flu treatment choice to patients in the future.